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A B S T R A C T
Background: Previous studies suggest an association between short-term exposure to carbon monoxide and
myocardial infarction. We performed a systematic review and meta-analysis to assess current evidence on this
association to support the update of the World Health Organization (WHO) Global Air Quality Guidelines.
Methods: We searched Medline, Embase and Cochrane Central Register of Controlled Trials to update the evi-
dence published in a previous systematic review up to 30th September 2018 for studies investigating the as-
sociation between short-term exposure to ambient carbon monoxide (up to lag of seven days) and emergency
department visits or hospital admissions and mortality due to myocardial infarction. Two reviewers assessed
potentially eligible studies and performed data extraction independently. Random-effects meta-analysis was
used to derive the pooled risk estimate per 1 mg/m3 increase in ambient carbon monoxide concentration. Risk of
bias in individual studies was assessed using a domain-based assessment tool. The overall certainty of the body of
evidence was evaluated using an adapted certainty of evidence assessment framework.
Results: We evaluated 1,038 articles from the previous review and our updated literature search, of which, 26
satisfied our inclusion criteria. Overall, myocardial infarction was associated with exposure to ambient carbon
monoxide concentration (risk ratio of 1.052, 95% confidence interval 1.017–1.089 per 1 mg/m3 increase). A
third of studies were assessed to be at high risk of bias (RoB) due to inadequate adjustment for confounding.
Using an adaptation of the Grading of Recommendations Assessment, Development and Evaluation (GRADE)
framework, the overall evidence was assessed to be of moderate certainty.
Conclusions: This review demonstrated that the pooled risk ratio for myocardial infarction was 1.052 (95% CI
1.017–1.089) per 1 mg/m3 increase in ambient carbon monoxide concentration. However, very few studies
originated from low- and middle-income countries.
1. Introduction
Air pollution is a major environmental hazard to human health and
a leading cause of mortality and morbidity worldwide. The World
Health Organization (WHO) has published several volumes of Global
Air Quality Guidelines (AQGs) to provide guidance to the public,
especially to policy and other decision makers, on the health risks of air
pollution. To incorporate the latest scientific evidence into the guide-
lines, an update of the WHO AQGs is currently coordinated by the WHO
Regional Office for Europe’s European Centre for Environment and
Health (ECEH) in Bonn (Germany). This systematic review and meta-
analysis on the association between short-term exposure to carbon
monoxide and ischaemic heart disease has been developed to support
this update.
Carbon monoxide is a colourless and odourless gas that is emitted
primarily from incomplete combustion of fossil fuels. The most well-
recognised pathophysiological effect of carbon monoxide is tissue hy-
poxia, due to its ability to bind with haemoglobin to form carbox-
yhaemoglobin. Controlled exposure studies have demonstrated that
carbon monoxide exacerbates myocardial ischaemia particularly in in-
dividuals with pre-existing coronary artery disease (Allred et al., 1989).
Furthermore, studies in cell and animal models at moderate to high
carbon monoxide concentrations have suggested other potential non-
hypoxic mechanisms such as oxidative stress, inflammation and en-
dothelial dysfunction (Thom et al., 1997, 1999; Lo Iacono et al., 2011).
A previous systematic review and meta-analysis has reported a
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significant association between short-term exposure to carbon mon-
oxide and risk of myocardial infarction (Mustafić et al., 2012). Since
then, numerous new epidemiological studies have been published. We
aim to update the previous review to incorporate these contemporary
studies into the AQGs and to evaluate the overall certainty of the evi-
dence of the effect estimate.
2. Methods
2.1. Search strategy and selection criteria
In this review, we updated a previous review by Mustafic et al which
ended their search on 28th November 2011 (Mustafić et al., 2012). We
searched Ovid MEDLINE, Ovid EMBASE and Cochrane Central Register
of Controlled Trials from 31st October 2011 to 30th September 2018
using combinations of the following keywords: “air pollution”, “carbon
monoxide”, “MI”, “heart attack”, “acute coronary syndrome” for studies
that matched our prespecified PECOS (Population, Exposure, Com-
parator, Outcome, Study design) criteria (Appendix 1). The full search
strategy is detailed in (Appendix 2). The protocol (World Health
Organization, 2014) was registered with the International Prospective
Register of Systematic Reviews (PROSPERO). The registration number
is CRD42017076081.
We evaluated studies from the previous review by Mustafić et al.
(2012) and the updated literature search that reported associations
between short-term exposure (in the order of hours up to 7 days) to
ambient air carbon monoxide and hospital admissions or mortality due
to myocardial infarction. We included studies in the adult general po-
pulation (over the age of 18 years) without geographical restrictions.
Studies that exclusively evaluated exposure to carbon monoxide in
occupational or indoor settings were excluded. We included myocardial
infarction as the only ischaemic heart disease outcome because it is not
possible to accurately define the time of onset of other ischaemic heart
disease outcomes such as angina which manifest over a period of
months to years. Furthermore, apart from myocardial infarction, other
conditions within the spectrum of ischaemic heart disease are routinely
managed in outpatient settings rather than in the Emergency Depart-
ment or necessitating hospital admissions. We included both time series
and case-crossover studies published in peer-reviewed journals with no
language restrictions. Systematic reviews of these studies were screened
for any additional articles.
Two reviewers (KKL & NS) independently screened titles and ab-
stracts identified from the systematic search using the prespecified
eligibility criteria. The full-texts of potentially relevant articles were
independently assessed by two reviewers (KKL & NS). Any disagree-
ment on inclusion was resolved by discussion and, if no consensus was
reached, a third reviewer was consulted (AS). Additional information
from study authors (where necessary) to resolve questions about elig-
ibility were obtained. Reasons for excluding articles at this stage were
recorded.
Full text screening and subsequent reviewer’s agreement were re-
corded in a list of included studies for systematic review, that was
circulated with the whole systematic review team and the WHO
Guideline Development Group to identify any additional potentially
relevant missing studies (published or in press). Where data from the
same study population, with complete geographical and temporal
overlap, was reported in multiple publications, only the largest and the
most complete study was included to avoid double counting.
2.2. Data extraction
Data extraction was conducted in duplicate but independently by
two authors (KKL & NS) using a standardised form which included a full
description of the study design, geographical location, characteristics of
the study population, details on air pollutant exposure (including unit
of measurement, mean/median, 5-95th percentile and range of
concentrations measured), details on co-exposures, details on outcome
assessment (ICD codes used or physician diagnosis), details of con-
founders measured and confounders adjusted for, data to calculate the
effect estimates and their confidence intervals most adjusted for con-
founders and conflicts of interest. All disagreements were resolved by
discussion. We contacted authors for additional data or clarification
where required.
2.3. Assessment of risk of bias
A new domain-based risk of bias (RoB) assessment instrument, de-
veloped by a working group of experts convened by WHO, was used to
assess all studies included in the meta-analysis (World Health
Organization, 2020).
The full details of the RoB assessment instrument, including the
detailed assessment criteria used for each domain, has been published
online by World Health Organization (2020). In brief, there are six
domains in the instrument: confounding, selection bias, exposure as-
sessment, outcome measurement, missing data and selective reporting.
Reviewer RoB judgments (high, moderate, low) were reported for each
RoB domain for all studies included in this review. Each domain con-
tains several subdomains. To come to an overall judgement for a do-
main, the following procedure was applied: if any of the subdomains
was rated as high risk of bias, the whole domain was rated as high risk
of bias; if all the subdomains was rated as low risk of bias, the whole
domain was rated as low risk of bias; when at least one subdomain was
rated as moderate risk of bias and none of the other subdomains was at
high risk of bias, the whole domain was rated as moderate risk of bias.
To evaluate each risk of bias domain independently, subgroup analyses
were considered for each domain where there is significant discordance
in the risk of bias rating.
All studies were independently assessed using the RoB tool by two
reviewers (KKL & NS). Any disagreement was resolved by discussion,
and if no consensus was reached, a third reviewed (AS) was consulted.
A WHO working group methodologist reviewed the RoB assessment of
10% of the included studies to ensure that the RoB assessment instru-
ment was applied accurately.
2.4. Data synthesis
Relative risk was used as the effect measure for the association
across all studies. Since the prevalence of ischaemic heart disease is
low, we considered hazard ratios and odds ratio as equivalent to re-
lative risk. We assumed a loglinear exposure-outcome relationship to
calculate relative risk for a standardized increment of 1 mg/m3 of
carbon monoxide across all studies. Risk estimates were therefore
standardised using the following formula:=RR (RR )[standardized] [original] Increment(1)/Increment(original)
2.5. Statistical analysis
Random effects meta-analysis was performed to pool risk estimates
across studies using the general inverse variance method. Where studies
have reported multiple risk estimates for subgroups of the study po-
pulation separately, estimates were combined using a random-effects
meta-analysis. The shortest time lag between exposure and outcome
presented in each study was used to calculate the pooled effect size. R
(version 3.5.1) was used to produce forest plots and to undertake
random-effects meta-analysis.
We constructed funnel plots to examine for publication bias and
assessed for asymmetry using Egger’s regression test. Statistical het-
erogeneity of effect estimates between studies (also inconsistency of
study results) was assessed using tau-squared and presented as 80%
prediction interval around the meta-estimate. This is different to the
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pre-specified protocol but following further deliberations by a WHO
working group on certainty of evidence assessment, this was considered
a more appropriate measure for statistical heterogeneity.
Where possible, we performed pre-specified analysis stratified by
time lags, study design (time series versus case-crossover), age>65
years versus ≤65 years, outcome: admission versus mortality, single
versus co-pollutant modelling, studies with conflict of interest versus
studies without conflicts of interest and stratified by risk of bias (high
risk of bias versus low or moderate risk of bias within each domain
where there was significant discordance across studies). We also per-
formed further post-hoc subgroup analyses stratified by outcome defi-
nition, multi-city versus single-city studies, median year of publication
and median pollutant concentration.
2.6. Evaluation of the certainty of evidence
The overall certainty of evidence was evaluated using an adaptation
of the Grading of Recommendations Assessment, Development and
Evaluation (GRADE) framework that was conducted by a working
group of experts convened by WHO (Morgan et al., 2019). Further in-
formation can be found in Appendix 3.
Due to the risk of unmeasured confounding in observational studies,
the rating process started at moderate certainty. The quality of evidence
was then downgraded or upgraded using prespecified criteria within
domains of evaluation. Reasons for downgrading include limitations in
studies, indirectness, inconsistency, imprecision and publication bias.
Reasons for upgrading include large magnitude of effect size, all plau-
sible confounding would shift relative risks towards the null and con-
centration–response gradient. The prespecified evaluation criteria used
for each domain are briefly summarised below.
Limitations in studies: The certainty of evidence was downgraded if
there were significant differences in the effect size in subgroup analyses
stratified by high versus moderate or low risk of bias.
Indirectness: The certainty of evidence was downgraded if there were
considerable differences between our prespecified PECOS of the sys-
tematic review and the PECOS used in the primary studies.
Inconsistency: This was evaluated by calculating the 80% prediction
interval of the overall pooled meta-estimate (IntHout et al., 2016). If
the 80% prediction interval was considerably wider than the confidence
interval and overlapped with 1, this indicated considerable hetero-
geneity and the quality of the body of evidence was downgraded.
Imprecision: This was evaluated by calculating the sample size re-
quired to conduct an adequately powered study to detect the pooled
risk estimate and confidence interval using the methodology developed
by Rothman and Greenland (2018). If the total number of individuals
across all studies included in the meta-analysis was considerably lower
than the number that would be needed for an adequately powered
study, the certainty of the evidence was downgraded because of
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imprecision.
Publication bias: The certainty of evidence was downgraded if pub-
lication bias was detected by visual inspection of the funnel plot and
confirmed using the Egger’s test.
Large effect size: Magnitude of the effect size was assessed by cal-
culating the E-value using the following formula:= +E - value RR sqrt(RR [RR 1])
The E-value quantifies the minimum strength of association on the
risk ratio scale that an unmeasured confounder must have to negate the
observed exposure-outcome association VanderWeele and Ding (2017)
Therefore the certainty of evidence was upgraded if the E-value was
substantially larger than the anticipated effect of a significant un-
measured confounder.
Confounding: The certainty of evidence was upgraded if the pooled
risk estimate was positive despite the presence of other plausible con-
founding factors that would shift the risk estimates towards a null as-
sociation.
Concentration–response gradient: The certainty of evidence was up-
graded if a concentration–response association was observed, either
linearly or non-linearly.
3. Results
Our updated literature search across MEDLINE, EMBASE and
Cochrane Central Register of Controlled Trials identified 1,332 articles.
A further twenty articles that were included in the previous systematic
review by Mustafic et al were also evaluated (Mustafić et al., 2012). The
study selection process is detailed in Fig. 1. Following removal of du-
plicates, we assessed the titles and abstracts of 1,038 articles and re-
viewed 54 full text articles in depth. Of these, 26 articles fulfilled the
inclusion criteria. This consists of 17 articles from the previous review
and 9 from the updated literature search. Three studies from the pre-
vious review were excluded due to complete geographical and temporal
overlap with a subsequent study (Bhaskaran et al., 2011) and incon-
sistency with our outcome of interest (Hoek et al., 2000; Stieb et al.,
2009).
A detailed description of the 26 studies included are presented in
Table 1. These studies originated from 14 different countries and were
mainly conducted from the 1980s and 1990s. Mean concentration of
carbon monoxide measured in these studies ranged from 0.3 mg/m3 to
4.6 mg/m3. Seventeen studies used a time series design and nine studies
used a case crossover design. Most studies identified events from ad-
ministrative databases using ICD-9 and ICD-10 codes. The majority of
studies presented risk estimates for hospitalisation due to myocardial
infarction (24 studies, 86%) whilst only 3 studies have reported risk
estimates for mortality due to myocardial infarction.
3.1. Overall analysis
The pooled relative risk across all included studies was 1.052 (95%
confidence interval [CI] 1.017 to 1.089) per 1 mg/m3 increase in
carbon monoxide concentration (Fig. 2). We observed significant het-
erogeneity for the overall pooled estimate (Tau2 = 0.006). The funnel
plot did not demonstrate any significant asymmetry (Fig. 3).
3.2. Risk of bias assessment
All 26 studies included in this review were evaluated using the RoB
instrument across 6 domains (Appendix 4). We summarized adjustment
for important confounders in the individual studies (seasonality, long-
term trends, temperature, day of week, humidity, pressure, influenza,
and holidays) in Table 1. There was significant variation in the ad-
justment for potential confounders across studies. All studies used ap-
propriate analysis methods or study design to control for confounders.
However, nine studies were assessed to be at high RoB for this domain.Ta
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Eight of these studies did not adjust for critical confounders such as
seasonality, long-term trends or day of the week and one study (Peters
et al., 2001) measured meteorological confounders from a single
monitoring station but extrapolated the measurements across a large
region. A further fifteen studies were assessed to be at moderate RoB for
this domain because holidays or influenza epidemics were not adjusted
in the analysis or the validity for measuring the meteorological con-
founders were insufficiently reported. Only two studies were at low RoB
for confounder adjustment (Bard et al., 2014; Eilstein et al., 2001).
The majority of studies selected individuals from large adminis-
trative or healthcare databases without selection bias. However, three
studies were assessed to be at high risk for selection bias. Two of these
studies only included a highly-selected group of patients who were well
enough to be interviewed (Peters et al., 2001; Berglind et al., 2010)
whilst another study (Nuvolone et al., 2011) excluded a significant
proportion of patients (14% of the total number of eligible patients)
who have experienced previous myocardial infarction. Two other stu-
dies were assessed to be at moderate risk of selection bias. Lanki et al.
(2006) only included patients below the age of 75 or 80 years whilst
Mann et al. (2002) included only residents who were members of a
regional healthcare insurance provider. These studies may have there-
fore introduced bias by selecting patients who have lower severity of
ischaemic heart disease, fewer comorbidities or those who have a
higher socioeconomic status.
25.115.0
Risk Ratio
Roye et al
Liu et al
Wang et al.1
Caussin et al
Wang et al.2
Bard et al
Milojevic at al
Lin et al
Tsai et al
Nuvolone et al
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Hseih et al
Cheng et al
Cendon et al
Lanki et al
Zanobetti et al
Barnett et al
Sullivan et al
Peters et al.1
Sharovsky et al
D'Ippoliti et al
Mann et al
Peters et al.2
Eilstein et al
Linn et al
Poloniecki et al
2018
2017
2015
2015
2015
2014
2014
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2010
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2009
2006
2006
2006
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2.74
4.93
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4.45
0.13
4.8
4.04
4.2
4.4
0.33
4.42
2.25
4.18
4.82
3.74
4.9
4.7
1
4.89
4.74
4.93
2.7
4.47
4.9
4.91
1.000 (0.870−1.150)
1.009 (1.000−1.017)
1.000 (0.998−1.003)
1.000 (0.905−1.105)
0.982 (0.933−1.034)
1.370 (0.533−3.486)
0.982 (0.956−1.009)
1.051 (0.975−1.130)
1.278 (1.197−1.365)
1.041 (0.980−1.094)
0.876 (0.493−1.574)
1.248 (1.183−1.316)
1.730 (1.454−2.042)
0.998 (0.934−1.067)
1.025 (1.000−1.051)
1.097 (1.000−1.193)
1.022 (1.008−1.037)
1.032 (0.992−1.065)
0.968 (0.712−1.320)
1.012 (0.995−1.029)
1.021 (0.988−1.054)
1.020 (1.013−1.028)
1.094 (0.949−1.260)
1.040 (0.988−1.093)
1.035 (1.020−1.051)
1.018 (1.006−1.031)
RE Model for All Studies (df = 25; 2 = 0.006),  Pooled risk ratio = 1.052 (95% CI 1.017 − 1.089)
Author(s) Year Weight, % Risk Ratio (95% CI)
Fig. 2. Forest plot of the association between carbon monoxide and admission for MI or mortality from MI across all included studies.
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All studies have measured exposure using daily averaged pollutant
concentration obtained from air quality monitoring stations based
within the cities. Two studies extrapolated pollutant measurements
from a single air quality monitoring station across a large city and was
therefore assessed to be at high risk of bias for exposure assessment
(Peters et al., 2001; Zanobetti and Schwartz, 2006).
All studies used hospital databases or regional health registries to
identify outcomes. These databases were linked with separate databases
containing air pollutant and meteorological measurements. All outcome
assessments were therefore blinded to the exposure measurement due
to the study design. Most studies used ICD-9 or ICD-10 codes (18 stu-
dies) and the remaining 8 studies used physician diagnoses to define
outcomes. All studies were therefore assessed to be at low risk of bias
for this domain.
The majority of studies did not report the percentage of missing data
but have utilised national or regional healthcare registries that were
judged to have infrequent missing data and were therefore assessed to
be at low risk of bias. Three studies were assessed to be at moderate risk
of bias because missing exposure data was not infrequent but appro-
priate methods had possibly been used to account for it (Bard et al.,
2014; Berglind et al., 2010; Lanki et al., 2006).
None of the studies had evidence of incomplete or selective re-
porting of effect estimates and therefore all were assessed to be at low
risk of bias for this domain.
3.3. Subgroup analyses
Only 14 studies reported risk estimates stratified by individual lag
days. Within this subset of studies, the association between carbon
monoxide and myocardial infarction was present for up to three days
before the event (lag 3, Fig. 4).
The association persisted when stratified by study design (Fig. 5).
Association with mortality from myocardial infarction was 1.004 (95%
CI 0.984 to 1.024), and 1.056 (95% CI 1.016 to 1.098) for hospitali-
sations due to myocardial infarction per 1 mg/m3 increase in carbon
monoxide concentration. Studies that defined myocardial infarction
using ICD coding had a pooled relative risk of 1.068 (1.016 to 1.124)
and those that utilised physician diagnosis had a pooled relative risk of
1.020 (0.997 to 1.044). Time series studies had pooled relative risk of
1.021 (95% CI 1.015 to 1.026) whilst case crossover studies had a
pooled relative risk of 1.082 (95% CI 1.017 to 1.150) per 1 mg/m3
increase in carbon monoxide concentration.
We performed subgroup analysis stratified by risk of bias due to
adjustment for confounding. Studies that were at low or moderate RoB
for this domain had a pooled relative risk of 1.082 (95% CI 1.020 to
1.148) per 1 mg/m3 increase in carbon monoxide concentration but the
association was attenuated in studies that were assessed to be at high
RoB (pooled relative risk of 1.007 [95% CI 1.002 to 1.011]). Because
very few studies were judged to be at high RoB in the other domains, no
further subgroup analysis for RoB was performed.
We also performed subgroup analyses stratified by median year of
publication and location of studies (1.022 [1.017–1.027] for studies
published before 2007 versus 1.090 [1.002–1.186] for studies pub-
lished from 2007 onwards and 1.012 [1.003–1.021] for multi-city
studies versus 1.094 [1.014–1.180] for single-city studies. Studies with
median carbon monoxide concentration below the median of 1.15 mg/
m3 had a pooled relative risk of 1.068 (95% CI 0.958 to 1.189) per
1 mg/m3 increment whilst studies with median carbon monoxide
concentration above 1.15 mg/m3 had a pooled relative risk of 1.044
(95% CI 1.006 to 1.082).
Meta-regression analysis across did not identify any statistically
significant heterogeneity across subgroups. We were not able to per-
form subgroup analysis by sex, age, multipollutant studies or conflict of
interest because there were too few studies reporting risk estimates
stratified by these subgroups.
3.4. Sensitivity analysis
Three studies (Hsieh et al., 2010; Cheng et al., 2009; Tsai et al.,
2012) performed by a single research group reported substantially
higher risk estimates compared to other included studies. Of these, two
had substantial temporal and geographical overlap (Hsieh et al., 2010;
Tsai et al., 2012). A sensitivity analysis was therefore performed ex-
cluding these studies (Appendix 6). The overall meta-estimate was
Fig. 3. Funnel plot.
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attenuated (pooled relative risk of 1.016 [95% CI 1.009 to 1.023]). All
three of these studies were assessed to be at moderate risk of bias.
Subgroup analysis stratified by risk of bias demonstrated less hetero-
geneity (1.019 [1.009–1.029] in studies at low/moderate risk of bias
versus 1.007 [1.002–1.011] for studies at high risk of bias; P-value for
meta-regression = 0.365).
4. Discussion
In this systematic review and meta-analysis update, we have iden-
tified ten additional studies evaluating the short-term effects of carbon
monoxide on admission to hospital for myocardial infarction or
mortality from myocardial infarction. After incorporating the newly
identified studies, our pooled estimate across 26 studies demonstrated
that the pooled risk ratio for myocardial infarction was 1.052 (95% CI
1.017 to 1.089; 80% prediction interval 0.95–1.16) per 1 mg/m3 in-
crease in ambient carbon monoxide concentration. The magnitude of
the association was very similar with the previous meta-analysis of 20
studies by Mustafić et al. (2012).
We identified 3 studies that reported substantially higher risk esti-
mates than other included studies (Hsieh et al., 2010; Cheng et al.,
2009; Tsai et al., 2012). These 3 studies were performed by the same
research group. Importantly, the ambient carbon monoxide con-
centrations in the cities at which the studies were conducted were
0.9 0.95 1 1.05 1.1
Risk Ratio
Lag 0
Lag 1
Lag 2
Lag 3
Lag 4
Lag 5
14
14
6
6
4
3
1.021 (1.013−1.030)
1.001 (0.999−1.004)
1.016 (1.008−1.024)
1.010 (1.001−1.018)
1.006 (0.998−1.014)
0.997 (0.989−1.006)
Lag (days) No. of 
 Estimates
Pooled risk ratios 
 [95% CI]
Fig. 4. Association between carbon monoxide and admission for MI or mortality from MI stratified by time lags.
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1.004 (0.984−1.024)
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Fig. 5. Association between carbon monoxide and admission for MI or mortality from MI stratified by subgroups. Abbreviations: ICD = international classification of
disease; RoB = risk of bias.
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relatively low, conversely, ambient nitrogen dioxide and PM10 con-
centrations were relatively high. Two-pollutant analyses performed in
these studies indicate that carbon monoxide may have been sub-
stantially correlated with other pollutants, therefore potentially con-
founding the risk estimates for carbon monoxide. Sensitivity analysis
excluding these studies attenuated the overall pooled risk estimates and
reduced the amount of heterogeneity across subgroups.
We evaluated the overall certainty of the evidence using the adapted
certainty of evidence assessment framework agreed by the Guideline
Development Group. First, a third of the studies had high risk of bias
due to inadequate adjustment for confounding. Subgroup analysis
showed that the risk estimate was lower in studies at high risk of bias
compared to those at low or moderate risk of bias although this was not
statistically significant. In sensitivity analyses excluding 3 outlying
studies, the subgroup risk estimates were similar. For this reason, we
have not downgraded the overall certainty of the evidence due to
limitations in the included studies. Second, studies included in the re-
view were consistent with the PECOS stated in our pre-specified elig-
ibility criteria; therefore, we did not downgrade due to indirectness.
Third, the 80% prediction interval of the pooled risk estimate ranged
from 0.871 to 1.271. However, most of the heterogeneity could be
explained by the 3 studies that reported outlying results. Sensitivity
analysis excluding these studies had an 80% prediction interval of
1.002–1.030. Therefore, the quality of the body of evidence was not
downgraded due to inconsistency. Fourth, the number of individuals
evaluated across the 30 studies included in this review was over 1.5
million. Although this is lower than the estimated sample size of 12.1
million required to assess the risk estimate using the calculation pro-
posed by Rothman and Greenland (2018) the included studies reported
risk estimates with sufficient precision. Furthermore, the calculation
involved a number of assumptions on the risk in the general population,
the proportion of the general population exposed to air pollution and
homogeneity of risk across diverse geographical regions. Therefore, we
have not downgraded the certainty of the evidence due to imprecision
of the pooled effect size. Finally, visual inspection of the funnel plot
does not indicate significant asymmetry therefore we have not down-
graded the evidence due to publication bias.
The overall risk estimate of 1.052 is modest. An E-value of 1.29 was
derived, however we have insufficient information to determine the
strength of association between an unmeasured confounder and our
outcome therefore we have not upgraded the certainty due to a large
effect size. We also did not upgrade the certainty of evidence due to
other plausible confounders as the direction of effect is unknown.
Furthermore, none of the studies have reported evidence of a dose–r-
esponse relationship between exposure to carbon monoxide and myo-
cardial infarction.
In summary, the overall quality of the evidence on the association
between short-term exposure to carbon monoxide and myocardial in-
farction was assessed to be of moderate certainty.
We acknowledge several limitations in this review. First, the vast
majority of studies originated from high-income countries with only
five out of thirty studies conducted in low- or middle-income countries.
This may limit the generalisability of our findings. Second, the pooling
of evidence from only observational studies is prone to bias. However,
this is an issue that is common to environmental epidemiological stu-
dies in this field where it is not possible to conduct a randomised
controlled trial. Finally, very few studies have performed multi-pollu-
tant analyses. Ambient carbon monoxide concentrations may be highly
correlated with other air pollutants such as nitrogen dioxide which may
significantly confound the observed risk estimates.
5. Conclusions
In conclusion, the pooled relative risk across for myocardial in-
farction was 1.052 (95% CI 1.017–1.089; 80% prediction interval
0.871–1.271) per 1 mg/m3 increase in ambient carbon monoxide
concentration. Overall, the evidence was assessed to be of moderate
quality. Further research in low- and middle-income countries is needed
to improve the generalisability of our findings.
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